P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy

Sconocchia, GArriga, RCaratelli, SCoppola, ASpagnoli, GCLanzilli, GCapuani, BFerrelli, FLauro, DFerrone, S2014-07-072014Sconocchia, G, R Arriga, S Caratelli, A Coppola, GC Spagnoli, G Lanzilli, B Capuani, F Ferrelli, D Lauro, and S Ferrone. 2014. “P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy.” Journal for Immunotherapy of Cancer 2 (Suppl 2): P7. doi:10.1186/2051-1426-2-S2-P7. http://dx.doi.org/10.1186/2051-1426-2-S2-P7.2051-1426http://nrs.harvard.edu/urn-3:HUL.InstRepos:12406751en-USP16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacyOther2014-07-0710.1186/2051-1426-2-S2-P7